DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,002,505 | -29.8% | 290,960 | +0.5% | 0.02% | -25.0% |
| Q2 2023 | $8,545,506 | +21.8% | 289,580 | -4.9% | 0.02% | +17.6% |
| Q1 2023 | $7,018,675 | -16.4% | 304,630 | +0.9% | 0.02% | -22.7% |
| Q4 2022 | $8,395,005 | -11.0% | 301,870 | -1.8% | 0.02% | -15.4% |
| Q3 2022 | $9,436,000 | +1.8% | 307,460 | -2.4% | 0.03% | +8.3% |
| Q2 2022 | $9,267,000 | -8.5% | 314,890 | 0.0% | 0.02% | +4.3% |
| Q1 2022 | $10,130,000 | -26.5% | 314,890 | +1.9% | 0.02% | -17.9% |
| Q4 2021 | $13,783,000 | -19.3% | 309,040 | -8.8% | 0.03% | -24.3% |
| Q3 2021 | $17,089,000 | -36.9% | 338,730 | -1.9% | 0.04% | -35.1% |
| Q2 2021 | $27,085,000 | +29.3% | 345,300 | -5.9% | 0.06% | +23.9% |
| Q1 2021 | $20,947,000 | -32.5% | 366,840 | -1.0% | 0.05% | -27.0% |
| Q4 2020 | $31,027,000 | +118.1% | 370,430 | -6.7% | 0.06% | +96.9% |
| Q3 2020 | $14,228,000 | +40.8% | 397,110 | -5.0% | 0.03% | +33.3% |
| Q2 2020 | $10,105,000 | +36.0% | 417,910 | -1.5% | 0.02% | +9.1% |
| Q1 2020 | $7,429,000 | -1.2% | 424,270 | -1.7% | 0.02% | +22.2% |
| Q4 2019 | $7,521,000 | +13.4% | 431,740 | -0.3% | 0.02% | +5.9% |
| Q3 2019 | $6,631,000 | -27.6% | 432,840 | -1.8% | 0.02% | -45.2% |
| Q2 2019 | $9,155,000 | -10.5% | 440,980 | +0.2% | 0.03% | -18.4% |
| Q1 2019 | $10,224,000 | +12.3% | 440,310 | -0.0% | 0.04% | 0.0% |
| Q4 2018 | $9,101,000 | -14.7% | 440,520 | -10.2% | 0.04% | 0.0% |
| Q3 2018 | $10,666,000 | +40.5% | 490,610 | -1.5% | 0.04% | +192.3% |
| Q2 2018 | $7,593,000 | -25.8% | 497,930 | -4.2% | 0.01% | -27.8% |
| Q1 2018 | $10,234,000 | +20.7% | 519,770 | -4.1% | 0.02% | +20.0% |
| Q4 2017 | $8,478,000 | – | 542,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |